Fayzan Rab: What are the economic and public health implications of psychedelic therapies?

Fayzan Rab, an MD Candidate at Emory University School of Medicine and clinical researcher at the Emory Center for Psychedelics and Spirituality, investigates the emerging psychedelic therapy landscape, including minority communities' perspectives and the public health and economic implications of these treatments. His background includes product development at Google and Mindstrong Health, grassroots political organizing, and executive coaching. In a Genomic Press Interview, he discusses the transformative potential of psychedelic therapy in modern healthcare.

Study at a glance

Abstract

At the intersection of medicine, psychedelics, and social impact stands Fayzan Rab, an MD Candidate at Emory University School of Medicine who brings a fascinating blend of experiences to his current role as a clinical researcher at the Emory Center for Psychedelics and Spirituality. His research explores crucial questions surrounding the emerging psychedelic therapy landscape, from understanding minority communities' perspectives to examining the broader public health and economic implications of these groundbreaking treatments. Before pursuing medicine, Fayzan carved out a distinctive path that included leading product development at tech giants Google and Mindstrong Health, followed by grassroots political organizing in the Bay Area. Today, alongside his research, he channels his leadership experience into executive coaching, helping entrepreneurs refine their communication skills and presence. When he is not exploring the frontiers of psychedelic medicine, Fayzan enjoys life in Atlanta with his fiancée Shua and their cat Bella, where you might find them hunting for fresh produce at their neighborhood farmer's market or hosting spirited game nights with friends. In this Genomic Press Interview, he shares his insights on the transformative potential of psychedelic therapy in modern healthcare.